Alerion Biomedical Inc.
Alerion Biomedical Inc. in San Diego is developing products for the detection, characterization and treatment of disease.
The company is developing technologies aimed at studying and managing major diseases including cancer, vascular disorders and hepatobiliary disease. Alerion’s latest product line, Fenestra™, is revolutionizing the way in vivo imaging is used in basic research and drug development.
Founded initially in 1997 as MetaProbe LLC by Research Corporation Technologies and the California Institute of Technology, Alerion Biomedical has grown to encompass a broad range of drug-delivery and medical imaging technologies.
Advanced Research Technologies Inc., a Canadian medical device company, acquired substantially all of the imaging technology and product assets of Alerion in March 2006. ART is actively promoting the Fenestra™ product line.
Inventors/Founders
Thomas J. Meade, Ph.D., Scott E. Fraser, Ph.D., Russell E. Jacobs, Wenhong Li, Ph.D., California Institute of Technology
RCT Contact
David Wiersma, Ph.D., Senior Associate